AEGON N.V. (NYSE:AEG) shares fell -0.90% in last trading session and ended the day at $5.48. AEG has a return on assets of 0.10%. AEGON N.V. (NYSE:AEG) quarterly performance is -5.52%.
International Flavors & Fragrances Inc. (NYSE:IFF) ended the last trading day at $115.88. Company weekly volatility is calculated as 1.97% and price to cash ratio as 34.15. International Flavors & Fragrances Inc. (NYSE:IFF) showed a weekly performance of -0.21%.
International Flavors & Fragrances Inc. (NYSE:IFF) announced that its Board of Directors has declared a regular quarterly cash dividend of $0.56 per share of the Company’s common stock, payable on January 7, 2016 to shareholders of record as of December 28, 2015.
On 18 December, KKR & Co. L.P. (NYSE:KKR) shares fell -1.27% and was closed at $15.56. KKR EPS growth in last 5 year was -22.50%. KKR & Co. L.P. (NYSE:KKR) year to date (YTD) performance is -28.07%.
KKR & Co. L.P., (NYSE:KKR) announced that it has re-launched its pioneering environmental initiative under a new name, and with an expanded mission. KKR’s eight-year-old Green Portfolio Program (GPP), which focused on promoting eco-efficiency best practices across participating portfolio companies, will be expanded to an initiative called the Green Solutions Platform (GSP).
TravelCenters of America LLC (NYSE:TA) shares fell -8.77% in last trading session and ended the day at $9.47. TA Gross Margin is 22.50% and its has a return on assets of 4.80%. TravelCenters of America LLC (NYSE:TA) quarterly performance is -23.32%.
TravelCenters of America LLC (NYSE:TA), operator of the TA® and Petro Stopping Centers® travel center brands, has announced the opening of a new Popeyes® Louisiana Kitchen at TA Tuscaloosa, located at I-20/I-59, Exit 77 (3501 Buttermilk Road), in Tuscaloosa, Alabama.
Cytori Therapeutics, Inc. (NASDAQ:CYTX) caters to the Healthcare space. Its weekly performance is -19.23%. On the last day of trading company shares ended up at $0.21. Cytori Therapeutics, Inc. (NASDAQ:CYTX) distance from 50-day simple moving average (SMA50) is 1.66%.
Cytori Therapeutics, Inc. (NASDAQ:CYTX) announced that it has received formal confirmation from The Nasdaq Stock Market LLC (“Nasdaq”) that Cytori’s request for an oral hearing with the Nasdaq Hearing Panel (“Panel”) has been granted. The hearing will occur on January 21, 2016 at Nasdaq’s Washington, D.C. offices. During the period prior to the hearing, Cytori’s common stock will continue to trade on The Nasdaq Global Market (“NGM”).
Leave a Reply